Pharmaceutical Markets in India
The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. This report Pharmaceutical Market in India provides market watchers with needed information on this growing market, including:
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2007. Historical data was provided for the years 2005 and 2006, with forecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for each region and/or segment covered. The forecasted market analysis for 2008-2012 was largely based on demographic trends, new developments, and global expansion.
- Market Size and Forecast
- Indian Market Share of Key Competitors
- Population and Epidemilogical Statistics for the Indian Market
- Pharmaceutical Market by Product Category
- Company Profiles of Global Companies
- Profiles of Key Domestic (Indian) Companies
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2007. Historical data was provided for the years 2005 and 2006, with forecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for each region and/or segment covered. The forecasted market analysis for 2008-2012 was largely based on demographic trends, new developments, and global expansion.
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER TWO: INTRODUCTION
CHAPTER THREE: MARKET ANALYSIS
CHAPTER FOUR: GLOBAL LEADERS
APPENDIX: LIST OF MAJOR COMPANIES
- Overview
- Scope and Methodology
- Size and Growth of the Market
- Key Issues and Trends Affecting the Market
- Leading Competitors
CHAPTER TWO: INTRODUCTION
- Overview
- Intellectual Property Rights and Compulsory Licensing
- Biosimilar Production
- Ethical Issues Regarding DTC Advertising in Developing Regions
- World Health
- Tobacco Use
- Obesity
- World Economic Trends
- Purchasing Power Trends
CHAPTER THREE: MARKET ANALYSIS
- Overview and Summary
- Regulatory Environment
- Economic Development
- Healthcare Trends in India,ul>
- Healthcare Professionals
- Demographics
- Birth Rates
- Life Expectancy
- Mortality
- Leading Causes of Death
- Key Product Segments and Market Indicators
- Cardiovascular Drugs
- Gastrointestinal Drugs
- Infection Control Drugs
- Neurotherapuetics and Central Nervous System Drugs
- Oncology Drugs
- Respiratory Drugs
- Other Drugs
- Market Analysis
- Product Segment Market Analysis
- Competitive Outlook and Distribution
CHAPTER FOUR: GLOBAL LEADERS
- Overview
- Biocon Ltd.
- Cipla Ltd.
- Dr. Reddy’s Laboratories Ltd.
- GlaxoSmithKline
- Pfizer, Inc.
- Ranbaxy
- Sanofi-Aventis
- Wockhardt Ltd.
APPENDIX: LIST OF MAJOR COMPANIES
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER TWO: INTRODUCTION
CHAPTER THREE: MARKET ANALYSIS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: India Pharmaceutical Market Analysis, 2005-2007
- Table 1-2: Forecasted India Pharmaceutical Market Analysis: 2008-2012
- Figure 1-1: India Pharmaceutical Market Analysis: 2005-2012
CHAPTER TWO: INTRODUCTION
- Table 2-1: Percent of Smokers by Country, Adult Population 15+
- Table 2-2: Percent of Population that is Obese*, Estimated 2005
- Table 2-3: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
- Figure 2-1: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
- Table 2-4: Gross National Income Comparison by Country 2000-2005
- Figure 2-2: Gross National Income Growth by Country 2000-2005
CHAPTER THREE: MARKET ANALYSIS
- Table 3-1: India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
- Figure 3-1: India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
- Table 3-2: India’s Economic Profile
- Table 3-3: Gross National Income Per Capita and Group Comparison for 2005 and 2006
- Table 3-4: Healthcare Professionals in India by Type, Estimated 2004 and 2007
- Figure 3-2: Healthcare Professionals in India by Type, Estimated 2004 and 2007
- Table 3-5: India - Midyear Population, by Age and Sex, 2007 and 2012
- Figure 3-3: India - Midyear Population, by Age, 2007 and 2012
- Table 3-6: India Fertility Rates and Births, Estimated 2005, 2007; Projected 2008, 2025
- Figure 3-4: India Fertility Rates and Births, Estimated 2005, 2007; Projected 2008, 2025
- Table 3-7: India Life Expectancy at Birth, 1980, 1990, 2000, 2004, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
- Figure 3-5: India Life Expectancy at Birth by Sex, 1980, 1990, 2000, Projections 2025
- Table 3-8: India Mortality Rates and Numbers, 2005, 2007; Projected 2008, 2025
- Figure 3-6: India Mortality Rates and Numbers, 2005, 2007; 2008, 2025
- Table 3-9: India Leading Causes of Death, Estimated 2007
- Figure 3-7: India Leading Causes of Death, Estimated 2007
- Table 3-10: HIV Indicators, India
- Figure 3-8: HIV Indicators, India:
- Table 3-11: Tuberculosis Surveillance and Epidemiology, India
- Figure 3-9: Tuberculosis Surveillance and Epidemiology, India
- Table 3-12: India Malaria Data, 1990-2003
- Figure 3-10: India Malaria Data, 1990-2003
- Table 3-13: Cancer Surveillance and Epidemiology, India
- Table 3-14: Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World
- Figure 3-12: Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World, 2007
- Table 3-15: India Pharmaceutical Market Analysis, 2005-2007
- Table 3-16: Forecasted India Pharmaceutical Market Analysis: 2008-2012
- Figure 3-13: India Pharmaceutical Market Analysis: 2005-2012
- Table 3-17: India Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012
- Figure 3-14: India Pharmaceutical Market Analysis by Product Segment, 2007
- Figure 3-15: India Pharmaceutical Market Forecast by Product Segment, 2012
- Table 3-18: Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007
- Figure 3-16: Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007
